WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices (GMP). After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. More information...
According to PR-model, wuxibiologics.com is ranked 464,297th in multilingual Wikipedia, in particular this website is ranked 226,764th in English Wikipedia.
The website is placed before thinkific.com and after heer.at in the BestRef global ranking of the most important sources of Wikipedia.